Nestle (NSRGF.PK) agrees to buy Prometheus Laboratories, a maker of treatments for cancer and...

|About: Nestle S.A. (NSRGF)|By:, SA News Editor

Nestle (NSRGF.PK) agrees to buy Prometheus Laboratories, a maker of treatments for cancer and gastrointestinal illnesses. Financial terms weren't disclosed, but Nestle may have paid 500M-1B Swiss francs ($567M-$1.1B) for the San Diego firm.